Tetraphase Pharmaceuticals Inc. (TTPH)

0.47
NASDAQ : Health Technology
Prev Close 0.54
Day Low/High 0.46 / 0.54
52 Wk Low/High 0.54 / 4.05
Avg Volume 532.30K
Exchange NASDAQ
Shares Outstanding 54.26M
Market Cap 29.31M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
5 Biotech Stocks Under $10 Triggering Breakout Trades

5 Biotech Stocks Under $10 Triggering Breakout Trades

Keep these under-$10 biotech stocks on your breakout trading radar.

Tetraphase Pharmaceuticals (TTPH) Is Today's Dead Cat Bounce Stock

Tetraphase Pharmaceuticals (TTPH) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Tetraphase Pharmaceuticals (TTPH) Showing Signs Of Perilous Reversal Today

Tetraphase Pharmaceuticals (TTPH) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "perilous reversal" (up big yesterday but down big today) candidate

10 Worst NASDAQ Biotech Stocks in the Third Quarter

10 Worst NASDAQ Biotech Stocks in the Third Quarter

The third quarter was brutal for biotech stocks. Here are the companies that fared the worst.

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Jim Cramer's 'Mad Money' Recap: Why Small Private Companies Should Be on Your Radar

Jim Cramer's 'Mad Money' Recap: Why Small Private Companies Should Be on Your Radar

Up-and-coming private companies are 'disruptors' that can take on their publicly traded peers like an oncoming train, Cramer says.

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Today's Weak On High Volume Stock: Tetraphase Pharmaceuticals (TTPH)

Today's Weak On High Volume Stock: Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Perilous Reversal Watch: Tetraphase Pharmaceuticals (TTPH)

Perilous Reversal Watch: Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "perilous reversal" (up big yesterday but down big today) candidate

Tetraphase Pharmaceuticals (TTPH) Is Strong On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Is Strong On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a strong on high relative volume candidate

Tetraphase Executive Profits Hours Before Stock Plummets

Tetraphase Executive Profits Hours Before Stock Plummets

A Tetraphase insider executed a well-timed insider stock sale right before the company's share price fell on negative clinical trial results.

Today's Dead Cat Bounce Stock Is Tetraphase Pharmaceuticals (TTPH)

Today's Dead Cat Bounce Stock Is Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Market Wrap: Giving It All Back and Then Some

U.S. stock finished in the red across the board after early gains.

Tetraphase Pharmaceuticals (TTPH) Stock Tanks on Weak Phase 3 Test Results

Tetraphase Pharmaceuticals (TTPH) Stock Tanks on Weak Phase 3 Test Results

Tetraphase Pharmaceuticals (TTPH) shares are down nearly 80% after the company announced that its urinary tract infection treatment failed a phase 3 test.

Analysts' Actions -- Mannkind, Micron, Ciena, Finisar and More

Analysts' Actions -- Mannkind, Micron, Ciena, Finisar and More

Here are Wednesday's top research calls, including ratings changes for Mannkind, Micron, Ciena and Finisar.

Today's Pre-Market Mover With Heavy Volume: Tetraphase Pharmaceuticals (TTPH)

Today's Pre-Market Mover With Heavy Volume: Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a pre-market mover with heavy volume candidate

Tuesday's Clinical Trial Scorecard: Akebia Wins, Tetraphase, Flexion, Theravance Lose

Tuesday's Clinical Trial Scorecard: Akebia Wins, Tetraphase, Flexion, Theravance Lose

Four biotech companies announced important clinical trials results Tuesday at market close.

First Week of TTPH October 16th Options Trading

First Week of TTPH October 16th Options Trading

Investors in Tetraphase Pharmaceuticals, Inc saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TTPH options chain for the new October 16th contracts and identified one put and one call contract of particular interest.

Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results

Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results

Company to Host Conference Call at 4:30 p.m. ET Today

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Tetraphase Pharmaceuticals (TTPH) Is Today's Strong On High Volume Stock

Tetraphase Pharmaceuticals (TTPH) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a strong on high relative volume candidate

Tetraphase Pharmaceuticals (TTPH) Hits New Lifetime High

Tetraphase Pharmaceuticals (TTPH) Hits New Lifetime High

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a new lifetime high candidate

TheStreet Quant Rating: D (Sell)